TUBA4A 抗体 (AA 20-183)
Quick Overview for TUBA4A 抗体 (AA 20-183) (ABIN7629017)
抗原
See all TUBA4A 抗体适用
宿主
克隆类型
标记
应用范围
- 
    
- 
                                            
抗原表位
 - AA 20-183
 - 
                                            
原理
 - TUBA4A Polyclonal Antibody
 - 
                                            
产品特性
 - The TUBA4A Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC, IF, IP.
 - 
                                            
纯化方法
 - Protein G purified
 - 
                                            
纯度
 - >95%
 - 
                                            
免疫原
 - Recombinant Human Tubulin alpha-4A chain protein
 - 
                                            
亚型
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Liquid
 - 
                                            
浓度
 - Lot specific
 - 
                                            
缓冲液
 - 0.03 % Proclin 300, 50 % glycerol, 0.01M PBS, pH 7.4
 - 
                                            
储存液
 - ProClin
 - 
                                            
注意事项
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
储存条件
 - 4 °C,-20 °C
 - 
                                            
储存方法
 - 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
 - 
                                            
有效期
 - 12 months
 
 - 
                                            
 - 
    
- TUBA4A (Tubulin, alpha 4a (TUBA4A))
 - 
                                            
别名
 - TUBA4A
 - 
                                            
UniProt
 - P68366
 - 
                                            
途径
 - Microtubule Dynamics, M Phase
 
抗原
 -